Yersinia pestis F1 antigen: A correlation between antibody titres and subclass distribution with differential avidity in different inbred mouse strains

International Immunopharmacology

Volumn 3, Issue 10-11, 2003, Pages 1413-1418

  Sabhnani, L ^a   Manocha, M ^a   Tomar, D ^a   Shashikiran, D ^b   Rao, D N ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF DELHI   (India)

Author keywords

Antibody; Avidity; F1 antigen; Plague

Indexed keywords

ANTIBODY; BACTERIAL ANTIGEN; F1 ANTIGEN; LIPOSOME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DELIVERY SYSTEM; IMMUNE RESPONSE; MOUSE; MOUSE STRAIN; NONHUMAN; YERSINIA PESTIS;

EID: 0041926618     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(03)00138-3     Document Type: Article

References (11)

1. World Health Organization Human plague in 1994. WHO Weekly Epidemiol Rec. 22:1996;165-168.
2. Simpson W.J., Thomas R.E., Schwan T.G. Recombinant capsular antigen (fraction 1) from Yersinia pestis induces a protective antibody response in BALB/c mice. Am. J. Trop. Med. Hyg. 43:1990;389-396.
3. Leary S.E., Williamson E.D., Griffin K.F., Russell P., Eley S.M., Titball R.W. Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague. Infect. Immun. 63:1995;2854-2858.
4. Sabhnani L., Rao D.N. Identification of immunodominant epitope of F1 antigen of Yersinia pestis. FEMS Immunol. Med. Microbiol. 27:2000;155-162.
5. Sabhnani L., Manocha M., Sridevi K., Shashikiran D., Rayanade R., Rao D.N. Developing subunit immunogens using B&T cell epitopes and their constructs derived from F1 antigen of Y. pestis using novel delivery vehicles. FEMS Immunol. Med. Microbiol. 2003;. [in press].
6. Eyles J.E., Sharp G.J., Williamson E.D., Spiers I.D., Alpar H.O. Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse. Vaccine. 16:1998;698-707.
7. Eyles J.E., Spiers I.D., Williamson E.D., Alpar H.O. Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines. Vaccine. 16:1998;2000-2009.
8. Ahluwalia A., Gokulan K., Nath I., Rao D.N. Modification of delivery system enhances MHC non-restricted immunogenicity of V3 loop region of HIV-1 gp120. Microbiol. Immunol. 41:1997;779-784.
9. Pullen G.R., Fitzgerald M.G., Hosking C.S. Antibody avidity determination by ELISA using thiocyanate elution. J. Immunol. Methods. 86:1986;83-87.
10. Alving C.R. Liposomes as carriers of antigens and adjuvants. J. Immunol. Methods. 140:1991;1-13.
11. Williamson E.D., Vesey P.M., Gillhespy K.J., Eley S.M., Green M., Titball R.W. An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin. Exp. Immunol. 116:1999;107-114.